Article
PKCθ/β and CYLD are antagonistic partners in the NFκB and NFAT transactivation pathways in primary mouse CD3+ T lymphocytes.
PloS one - 1 Jan 2013
Thuille Nikolaus, Wachowicz Katarzyna, Hermann-Kleiter Natascha, Kaminski Sandra, Fresser Friedrich, Lutz-Nicoladoni Christina, Leitges Michael, Thome Margot, Massoumi Ramin, Baier Gottfried
Abstract excerpt
In T cells PKCθ mediates the activation of critical signals downstream of TCR/CD28 stimulation. We investigated the molecular mechanisms by which PKCθ regulates NFκB transactivation by examining PKCθ/β single and double knockout mice and observed a redundant involvement of PKCθ and PKCβ in this signaling pathway. Mechanistically, we define a PKCθ-CYLD protein complex and an interaction between the positive PKCθ/β...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
